Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Early Everolimus with Low Dose Cyclosporine in Kidney Transplant
NCT01706471Phase 4Completed
- Sponsor
- Yonsei University
- Start
- Jun 2009
- Primary completion
- Jan 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of everolimus in kidney transplant rejection (2 arms), sponsored by Yonsei University. Primary endpoint: Reduced Exposure Cyclosporine in Renal Transplant Recipients at 12 months. Started Jun 2009; status: completed.
02
Drugs
everolimus
03
Conditions
kidney transplant rejection
Beyond the preview
Go deeper on NCT01706471.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01706471.